3 key areas for consideration to develop a biosimilar implementation
strategy
The considerations below may help you develop the implementation strategy
that will be most effective at your institution. They have been organized
into 3 areas and align with the 4 key operational areas for biosimilar
implementation –
Operational Enablement, Informatics/IT, Education, and
Monitoring.
Operational enablement
-
Integrate the benefits verification process with electronic health
record (EHR) systems to facilitate a quick order process
-
Set up biosimilar prior authorizations in the EHR to ensure
coverage
-
Develop a patient transition plan for how biosimilar transitions
will be sequenced (eg, all at once, phased in by clinic or
therapeutic area, existing vs treatment-naive patients)
-
Identify where the product will be stored and how much should be
stocked
-
Evaluate what inventory management system modifications need to be
made (including automated dispensing devices and software) to
integrate the biosimilar and enable accurate identification
Informatics/IT
-
Identify what modifications need to be made to existing order
sets and protocols to include biosimilar products
-
Plan for converting patient orders (eg, new vs established
patients, single order vs treatment plan, route for cosignature)
-
Determine which EHR functionality/interface can be leveraged to
support the organization’s biosimilar conversion goals
Education
-
Identify the most critical stakeholders to target for biosimilar
education
-
Determine what education stakeholders will need to prepare for
biosimilar adoption
- Select who will be responsible for patient education
-
Identify which patient education materials will be needed to
support biosimilar use
Monitoring
-
Determine how the institution will ensure that biosimilar protocol
is followed
-
Identify how financial and drug use evaluation outcomes will be
monitored in order to determine if value of the biosimilar was
achieved
Click below to access a series of pharmacist-led videos that offer even more considerations that may
help you develop a biosimilar implementation strategy for your organization.
Informational Videos for pharmacy and health information technology
